Views 263
Citations 0
Comment & Response
July 5, 2016

Acetazolamide and Invasive Mechanical Ventilation for Patients With COPD—Reply

Author Affiliations
  • 1Assistance Publique-Hôpitaux de Paris, Paris, France

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;316(1):100-101. doi:10.1001/jama.2016.4625

In Reply Dr Contou and colleagues underline the importance of monitoring fluid management, especially in patients with COPD.1 They correctly indicate that acetazolamide has a weak natriuretic effect.2 Loop diuretics may be required while attempting to discontinue mechanical ventilation.3 In the DIABOLO trial, the 2 treatment groups did not differ regarding the use of loop diuretics (median, 1; range, 0 to 4 days for the acetazolamide group vs median, 1; range, 0 to 4 days for the placebo group; P = .55). Moreover, left ventricular ejection fraction did not differ between groups at the time of weaning (median, 55%; range, 40%-60% for the acetazolamide group vs median, 50%; range, 42%-60% for the placebo group; P = .86). Weaning failure due to left ventricular insufficiency occurred in 8 patients (4.3%) in the acetazolamide group and 6 patients (3.1%) in the placebo group (P = .41), indicating a conservative approach regarding fluid management. An accurate estimation of body water composition remains challenging in critically ill patients.4

First Page Preview View Large
First page PDF preview
First page PDF preview